Jahres-Antikörperprofile von Pferdegruppen eines isoliert gehaltenen Bestandes nach unterschiedlich terminisierter Anwendung eines viralen Kombinations-Versuchsimpfstoffs.

Translated title of the contribution: Year-round antibody profile of groups of horses of a herd kept in isolation after differently terminating use of an experimental viral combination vaccine

F. Bürki, N. Nowotny, A. Hofer

Research output: Contribution to journalArticle

Abstract

The commercial vaccine "Resequin F Konz." devised against viral respiratory infections of horses contains the abortigenic Equine Herpesvirus-1 (EHV-1). Therefore we had used it in our protection project of the Austrian Lipizzaners+ primarily to prevent abortions. Taking into account the recent perception that for young horses the respiratory-pathogenic EHV-4 type is essential Behringwerke Marburg added this particular virus to their market product to produce a multicomponent experimental vaccine. We examined this vaccine for its antibody induction as well as their persistence against each of its viral components. On groups of foals we did this regarding its prophylactic effect against respiratory infections. Furthermore, we investigated its immunogenicity in adult horses, hoping for a potentiating effect of EHV-4 against EHV-1, mediating enhanced protection against abortion caused by the latter virus. This experimental vaccine proved excellently tolerable, its immunogenicity against either equine herpesvirus type was considerable, was very good against both equine influenza subtypes, was low, however, against retroviruses types 1 and 3. Recommendations are made for seasonal optimal spacing of vaccinations, taking into account the prevalent dissemination phases of the viruses involved, the different age groups of horses and their respective use.

Original languageGerman
Pages (from-to)82-89
Number of pages8
JournalDeutsche Tierarztliche Wochenschrift
Volume98
Issue number3
Publication statusPublished - Mar 1991

Fingerprint

Viral Vaccines
Combined Vaccines
Horses
herds
vaccines
horses
antibodies
Equid herpesvirus 4
Antibodies
Equid Herpesvirus 4
Vaccines
Equid herpesvirus 1
Equid Herpesvirus 1
abortion (animals)
viruses
Viruses
Retroviridae
Respiratory Tract Infections
immune response
equine influenza

ASJC Scopus subject areas

  • veterinary(all)

Cite this

@article{fe9f6428769640ab9c7d7316eaa3510d,
title = "Jahres-Antik{\"o}rperprofile von Pferdegruppen eines isoliert gehaltenen Bestandes nach unterschiedlich terminisierter Anwendung eines viralen Kombinations-Versuchsimpfstoffs.",
abstract = "The commercial vaccine {"}Resequin F Konz.{"} devised against viral respiratory infections of horses contains the abortigenic Equine Herpesvirus-1 (EHV-1). Therefore we had used it in our protection project of the Austrian Lipizzaners+ primarily to prevent abortions. Taking into account the recent perception that for young horses the respiratory-pathogenic EHV-4 type is essential Behringwerke Marburg added this particular virus to their market product to produce a multicomponent experimental vaccine. We examined this vaccine for its antibody induction as well as their persistence against each of its viral components. On groups of foals we did this regarding its prophylactic effect against respiratory infections. Furthermore, we investigated its immunogenicity in adult horses, hoping for a potentiating effect of EHV-4 against EHV-1, mediating enhanced protection against abortion caused by the latter virus. This experimental vaccine proved excellently tolerable, its immunogenicity against either equine herpesvirus type was considerable, was very good against both equine influenza subtypes, was low, however, against retroviruses types 1 and 3. Recommendations are made for seasonal optimal spacing of vaccinations, taking into account the prevalent dissemination phases of the viruses involved, the different age groups of horses and their respective use.",
author = "F. B{\"u}rki and N. Nowotny and A. Hofer",
year = "1991",
month = "3",
language = "German",
volume = "98",
pages = "82--89",
journal = "Deutsche Tierarztliche Wochenschrift",
issn = "0341-6593",
publisher = "Verlag M. und H. Schaper GmbH",
number = "3",

}

TY - JOUR

T1 - Jahres-Antikörperprofile von Pferdegruppen eines isoliert gehaltenen Bestandes nach unterschiedlich terminisierter Anwendung eines viralen Kombinations-Versuchsimpfstoffs.

AU - Bürki, F.

AU - Nowotny, N.

AU - Hofer, A.

PY - 1991/3

Y1 - 1991/3

N2 - The commercial vaccine "Resequin F Konz." devised against viral respiratory infections of horses contains the abortigenic Equine Herpesvirus-1 (EHV-1). Therefore we had used it in our protection project of the Austrian Lipizzaners+ primarily to prevent abortions. Taking into account the recent perception that for young horses the respiratory-pathogenic EHV-4 type is essential Behringwerke Marburg added this particular virus to their market product to produce a multicomponent experimental vaccine. We examined this vaccine for its antibody induction as well as their persistence against each of its viral components. On groups of foals we did this regarding its prophylactic effect against respiratory infections. Furthermore, we investigated its immunogenicity in adult horses, hoping for a potentiating effect of EHV-4 against EHV-1, mediating enhanced protection against abortion caused by the latter virus. This experimental vaccine proved excellently tolerable, its immunogenicity against either equine herpesvirus type was considerable, was very good against both equine influenza subtypes, was low, however, against retroviruses types 1 and 3. Recommendations are made for seasonal optimal spacing of vaccinations, taking into account the prevalent dissemination phases of the viruses involved, the different age groups of horses and their respective use.

AB - The commercial vaccine "Resequin F Konz." devised against viral respiratory infections of horses contains the abortigenic Equine Herpesvirus-1 (EHV-1). Therefore we had used it in our protection project of the Austrian Lipizzaners+ primarily to prevent abortions. Taking into account the recent perception that for young horses the respiratory-pathogenic EHV-4 type is essential Behringwerke Marburg added this particular virus to their market product to produce a multicomponent experimental vaccine. We examined this vaccine for its antibody induction as well as their persistence against each of its viral components. On groups of foals we did this regarding its prophylactic effect against respiratory infections. Furthermore, we investigated its immunogenicity in adult horses, hoping for a potentiating effect of EHV-4 against EHV-1, mediating enhanced protection against abortion caused by the latter virus. This experimental vaccine proved excellently tolerable, its immunogenicity against either equine herpesvirus type was considerable, was very good against both equine influenza subtypes, was low, however, against retroviruses types 1 and 3. Recommendations are made for seasonal optimal spacing of vaccinations, taking into account the prevalent dissemination phases of the viruses involved, the different age groups of horses and their respective use.

UR - http://www.scopus.com/inward/record.url?scp=0026117210&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026117210&partnerID=8YFLogxK

M3 - Article

C2 - 1646100

AN - SCOPUS:0026117210

VL - 98

SP - 82

EP - 89

JO - Deutsche Tierarztliche Wochenschrift

JF - Deutsche Tierarztliche Wochenschrift

SN - 0341-6593

IS - 3

ER -